Medicare Enrolled

Dr. Leonard Altman, M.D.

Allergy & Immunology · Seattle, WA
Speaking/Promotional
9725 3RD AVE NE STE 500, Seattle, WA 98115
2065271200
In practice since 2006 (20 years)
NPI: 1407892466 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Altman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Altman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Altman

Dr. Leonard Altman is an allergy & immunology specialist in Seattle, WA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Altman received a total of $161,078 from 27 pharmaceutical and/or device companies across 396 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Altman is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $161,078 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$161,078
Total received (2018-2024)
Avg $23,011/year across 7 years
Top 3% in WA for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
396
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$134,148 (83.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$17,937 (11.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,993 (5.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,748
2023
$1,936
2022
$23,155
2021
$9,354
2020
$10,428
2019
$29,437
2018
$81,020

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Pharming Healthcare, Inc.
$2,713
Takeda Pharmaceuticals U.S.A., Inc.
$1,375
GENZYME CORPORATION
$488
AstraZeneca Pharmaceuticals LP
$440
BioCryst US Sales Co., LLC
$266
ADMA BioManufacturing LLC
$229
Blueprint Medicines Corporation
$151
Cardinal Health 110 LLC
$50
Amgen Inc.
$23
Genentech USA, Inc.
$14
Top 3 companies account for 79.6% of 2024 payments
All-time payments by company (2018-2024) ›
Shire North American Group Inc
$98,615
BioCryst US Sales Co., LLC
$22,628
Pharming Healthcare, Inc.
$12,302
Takeda Pharmaceuticals U.S.A., Inc.
$7,536
Cardinal Health 110 LLC
$5,400
Cardinal Health 110, LLC
$4,000
AstraZeneca Pharmaceuticals LP
$3,177
BioCryst Pharmaceuticals, Inc.
$2,750
GENZYME CORPORATION
$2,116
Regeneron Healthcare Solutions, Inc.
$374
Novartis Pharmaceuticals Corporation
$304
ALK-Abello, Inc
$280
ADMA BioManufacturing LLC
$260
Genentech, Inc.
$238
Boehringer Ingelheim Pharmaceuticals, Inc.
$209
Blueprint Medicines Corporation
$151
CSL Behring
$147
Horizon Pharma plc
$132
GlaxoSmithKline, LLC.
$116
kaleo, Inc.
$74
PFIZER INC.
$69
Teva Pharmaceuticals USA, Inc.
$63
Kaleo, Inc.
$59
Amgen Inc.
$23
Optinose US, Inc.
$21
Circassia Pharmaceuticals Inc
$21
Genentech USA, Inc.
$14
Top 3 companies account for 82.9% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · AIRSUPRA · AUVI-Q · AYVAKIT · AirDuo Digihaler · Auvi-Q · BREO · BREZTRI · CINRYZE · CUVITRU · DISEASE STATE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EUCRISA · FASENRA · FIRAZYR · GAMMAGARD · Grastek · Haegarda · Hizentra · JOENJA · NUCALA · ORLADEYO · Odactra · Orladeyo · RUCONEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · XOLAIR · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in allergy & immunology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for allergy & immunology in WA.

Looking for an allergy & immunology specialist in Seattle?
Compare allergy & immunologists in the Seattle area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists within 10 mi
43
Per 100K population
1.9
County median income
$122,148
Nearest hospital
SEATTLE CHILDREN'S HOSPITAL
1.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Altman is an allergy & immunology specialist, with speaking/promotional industry engagement in the top 3% of WA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Altman receive payments from pharmaceutical companies?
Yes. Dr. Altman received a total of $161,078 from 27 companies across 396 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Altman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →